New cancer drug shows promise in mesothelioma trial

New cancer drug shows promise in mesothelioma trial. Mesothelioma is a rare but aggressive cancer, usually caused by exposure to asbestos.

A apuração publicada por medicalxpress.com vira base para uma leitura editorial direta e contextualizada.

Trechos de apoio da pauta: Mesothelioma is a rare but aggressive cancer, usually caused by exposure to asbestos. Inhaled asbestos fibers become lodged in the lungs, causing inflammation that can lead to tumor formation decades later.

• Ponto de atenção: cancer.
• Ponto de atenção: drug.
• Ponto de atenção: shows.

Em resumo, a leitura editorial acompanha o impacto do tema no nicho Fitness.